TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

SHENKMAN CAPITAL MANAGEMENT INC's Holding History (CIK: 0001275228)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 6,662,000 Value ($000) $9,754 Avg Close — Range —
Q3 2025
Shares 6,237,000 Value ($000) $7,216 Avg Close — Range —
Q2 2025
Shares 5,641,000 Value ($000) $5,677 Avg Close — Range —
Q1 2025
Shares 6,874,000 Value ($000) $7,155 Avg Close — Range —